Page 10 - Genome Sciences News Today

A new study led by Washington University School of Medicine and the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, shows that a standard milk-based therapy plus treatment with a specific strain of gut bacteria reduces gut inflammation and promotes weight gain in infants with severe acute malnutrition.

Gut microbiome pioneer Jeffrey Gordon, MD, of Washington University School of Medicine, is the 2022 Senior Scientist Winner of the Innovators in Science Award. The award recognizes his outstanding contributions to the field of gastroenterology.

Takeda (TSE:4502/NYSE:TAK) and the New York Academy of Sciences today announced the winners of the fourth Innovators in Science Award for their excellence in, and commitment to, innovative science that has significantly advanced the field of research in gastroenterology. Each winner receives an unrestricted prize ...

A new internal review of Duke’s university-wide institutes, initiatives and centers (UICs) underscores their role in fostering intellectual communities that cross school and departmental boundaries

Dr. Carla Daniela Robles-Espinoza is one of the most knowledgeable researchers on one of the most mysterious types of skin cancer.

Dr. Carla Daniela Robles-Espinoza is one of the most knowledgeable researchers on one of the most mysterious types of skin cancer.

AAAS unanimously appointed two new directors at its December 2021 meeting. Biologist Juan S. Ramírez Lugo, Ph.D., and electrical engineer Babak Parviz, Ph.D., officially began their service at the Board’s February 2022 meeting.

The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.

The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.

Part of her talk will be devoted to a potential treatment for sufferers of severe COVID-19 disease and for long haulers.